Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chembio Diagnostics Inc (NASDAQ:CEMI)

8.52
Delayed Data
As of May 27
 +0.16 / +1.91%
Today’s Change
3.33
Today|||52-Week Range
9.40
+59.85%
Year-to-Date
No recent news for Chembio Diagnostics Inc.

Today’s Trading

Previous close8.36
Today’s open8.28
Day’s range8.14 - 8.52
Volume45,552
Average volume (3 months)37,549
Market cap$80.7M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-108.33%
Earnings growth (this year)+16.00%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-12.26%
P/E ratioNM
Price/Sales2.12
Price/Book4.56

Competitors

 Today’s
change
Today’s
% change
NWBONorthwest Biotherape...+0.00+0.06%
XOMAXOMA Corp+0.01+1.23%
DRNADicerna Pharmaceutic...+0.01+0.27%
REPHRecro Pharma Inc-0.04-0.49%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$24.3M
Annual profit (last year)-$2.4M
Net profit margin-9.88%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
John J. Sperzel
Chief Operating Officer
Sharon Klugewicz
Corporate headquarters
Medford, New York

Forecasts

Partner Offers

Search for Jobs